The case for value‑based healthcare

• Value-based healthcare (VBHC) shifts payment from volume to outcomes, improving survival, function, and quality of life with less waste
• Patient-reported outcomes and remote monitoring turn check-ins into real-time insights that enable earlier action and fewer admissions
• Representing only about 2% of healthcare spending, diagnostic tests guide most clinical decisions and help deliver faster, more effective care

Health systems are reimbursed for every appointment, test, or procedure — whether or not those interventions restore health. Since 2005, the annual cost of care for a typical US family of four has climbed from $USD 12,214 to $USD 35,119 in 2025, nearly tripling.^1,2

Yet outcomes have not kept pace with rising costs. Value-based healthcare (VBHC) offers an alternative: a patient-centered approach that measures health outcomes against the cost of care to improve results for patients. In practice, this means focusing on survival, functional status, and quality of life alongside efficient use of healthcare resources.^3,4

Value‑based healthcare (VBHC) is an increasingly important healthcare paradigm that focuses on maximizing health outcomes relative to the cost of care delivered. In a fee‑for‑service world, clinicians are paid for every service delivered. In VBHC, they are paid for improving health and quality of life.²

VBHC aims to make health systems more efficient and effective by shifting focus from volume to value. With rising costs and ongoing inequities, it is now a priority for policymakers, providers, and payers alike.²

Value-based healthcare examples include the Centers for Medicare & Medicaid Services in the United States, which aims for all beneficiaries to be in value‑based arrangements by 2030.⁵ Similar shifts are underway elsewhere: in England, the NHS payment framework increasingly uses best-practice and quality-linked tariffs to reward achievement of defined standards of care, while in the Netherlands, national bundled payments for chronic conditions such as diabetes, chronic obstructive pulmonary disease (COPD), and vascular risk management pay a single fee for the full cycle of care to support better coordination.^6,7

Achieving this vision requires collecting robust outcome data, reorganizing services around patient needs, and aligning financial incentives.

Counting visits or tests is easy, but these metrics reveal little about whether care actually improves a person’s life. Patients care about outcomes: Did treatment relieve their pain? Can they work and enjoy time with loved ones?

Essential tools for capturing what matters to patients are the patient‑reported outcome measures (PROMs). These standardized questionnaires ask individuals about symptoms, functional ability, and quality of life. Unlike satisfaction surveys, PROMs assess the real health impact of care. When integrated into routine practice, they promote shared decision‑making and allow reimbursement to be tied to results.^8,9

Coupling PROMs with remote patient monitoring and wearable devices gives care teams continuous insight into chronic disease trajectories. For instance, electronic PROMs and sensors can alert clinicians to early signs of deterioration, enabling prompt intervention and reducing hospitalizations.¹⁰

Implementing VBHC requires selecting metrics that reflect what truly matters to patients and clinicians. Common categories for patient‑centered outcomes include: ^9,11

• Survival and complications: Mortality rates and adverse events, such as surgical infections or medication errors, indicate whether care prevents death and avoids harm.

• Functional status and quality of life: Measures like the 36‑Item Short Form Survey (SF‑36) or the Oswestry Disability Index capture a patient’s ability to perform daily activities without pain or fatigue, emotional wellbeing, and social participation.

• PROMs: Track pain intensity, fatigue, mood, cognitive function, and mobility. For example, the University of Pittsburgh Medical Center uses the SF‑36 in primary care to detect depression and mobility issues. Such data reveal the lived impact of disease and treatment.

• Long‑term sustainability: Measures such as remission duration, recurrence rates, or ability to live independently evaluate whether benefits are durable.

Selecting the right metrics depends on the condition, treatment, and patient population. Risk adjustment for age, comorbidities, and socioeconomic status ensures fair comparisons between providers. 

Healthcare leaders should collaborate with patients and frontline clinicians to determine which outcomes matter most and incorporate these measures into reporting, decision-making, and reimbursement strategies for a robust value-based healthcare model.

Laboratory testing is a fundamental component of patient assessment and clinical decision-making, particularly in acute care, where timely and accurate results directly support diagnosis and treatment.^12,13

In a value-based healthcare model, their impact on patient outcomes far outweighs their cost. When tests are ordered appropriately and results delivered quickly, they enable early detection, guide personalized therapy, and monitor disease progression. When misused, they can cause delays, misdiagnosis, or unnecessary procedures. Laboratory professionals play a critical role by delivering accurate results rapidly, developing advanced biomarker and genetic tests, and guiding appropriate ordering.

Over-requesting of laboratory tests is recognised as a common issue in many healthcare systems, where panels may include tests that are not clinically necessary for the patient’s condition. Conversely, the right tests at the right time can detect disease earlier and prevent costly complications. For example, high-sensitivity cardiac troponin assays may enable faster diagnostic pathways, with some studies proposing testing intervals of one to two hours to support more rapid rule-out of a heart attack.¹⁴

In a value‑based environment, labs are judged not by volume, but by whether results support timely clinical action and improved patient outcomes^.12,13

Value‑based care isn’t just a theory; health systems are already using outcomes measurement to improve care and reduce costs: ¹¹

• Dartmouth‑Hitchcock Spine Center publishes PROMs for spine surgery, enabling clinicians and patients to compare interventions and drive quality improvement

• University of Pittsburgh Medical Center embeds the SF‑36 survey into primary care to screening for depression and mobility issues, enabling timely referrals

These examples show that when healthcare organizations measure and act on patient outcomes, they improve care quality, empower patients, and generate savings.

VBHC faces several practical hurdles. Many organizations lack interoperable systems that combine lab, clinical, and patient‑reported data. Without this integration, it’s difficult to track a patient’s journey or calculate the total cost of care. Attributing outcomes to specific interventions is also complex when patients see multiple clinicians, making accurate risk adjustment essential. Collecting PROMs can disrupt workflows and depends on patient engagement. 

Finally, many VBHC contracts require providers to accept downside risk, which can deter smaller practices that lack data analytics or care coordination resources.^9,11

Overcoming these hurdles requires investment in interoperable data platforms, leadership commitment to outcome transparency and support for teams to embed these practices into everyday workflows.⁹

Several payment models align reimbursement with outcomes, rewarding providers for delivering better care rather than more care. 

Common approaches to value-based payment in healthcare include:^2,4,15

• Pay‑for‑performance: Adds bonuses for meeting defined quality targets, providing incentive on top of traditional fee‑for‑service payments.

• Shared savings: Providers share cost savings with payers when expenditures fall below benchmarks. Some contracts also share losses, creating accountability for both quality and efficiency.

• Bundled payments: A single payment covers all services related to a condition or episode of care, encouraging coordination and reducing duplication.

• Capitation or global budgets: Providers receive a fixed payment per patient over a set period, assuming risk while emphasizing prevention and chronic disease management.

Hybrid arrangements often blend these models, and payers expect alternative contracts to grow. Robust outcome measurement ensures that payments reward quality rather than mere cost reduction.

Putting value‑based care into practice requires both vision and discipline. Organizations can start by defining meaningful outcomes, embedding outcome surveys and data capture into electronic health records, investing in analytics platforms, and engaging patients through portals or automated messaging.⁹

Early pilot projects focused on specific conditions can build momentum, while collaborations with payers and community partners help scale successful models.⁹

Data is the lifeblood of VBHC. Integrated information systems and predictive analytics allow providers to monitor performance, identify high‑risk patients, and tailor interventions. Remote monitoring devices extend care into the home, providing continuous tracking of vital signs and activity. 

Looking ahead, outcome measures will become more personalized and predictive. Telehealth and home diagnostics will expand access. Social determinants of health will increasingly shape care models, and risk‑based contracts will continue to grow. Laboratory innovations, from point‑of‑care tests to multiplex assays, will make diagnostics faster and more precise.

Throughout all these changes, patient outcomes remain the compass. Measuring survival, function, and quality of life—and acting on those insights—enables care that is both high-quality and cost-effective.